Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Silo Pharma (SILO) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Silo Pharma (SILO) over the last 13 years, with Q3 2025 value amounting to $1.1 million.

  • Silo Pharma's Operating Expenses rose 1190.15% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.4 million, marking a year-over-year increase of 2989.08%. This contributed to the annual value of $4.8 million for FY2024, which is 2167.6% up from last year.
  • According to the latest figures from Q3 2025, Silo Pharma's Operating Expenses is $1.1 million, which was up 1190.15% from $1.3 million recorded in Q2 2025.
  • Silo Pharma's 5-year Operating Expenses high stood at $1.8 million for Q4 2024, and its period low was $453415.0 during Q2 2021.
  • Over the past 5 years, Silo Pharma's median Operating Expenses value was $965720.0 (recorded in 2022), while the average stood at $985418.2.
  • The largest annual percentage gain for Silo Pharma's Operating Expenses in the last 5 years was 47511.47% (2021), contrasted with its biggest fall of 5454.83% (2021).
  • Silo Pharma's Operating Expenses (Quarter) stood at $958982.0 in 2021, then surged by 74.51% to $1.7 million in 2022, then fell by 29.47% to $1.2 million in 2023, then surged by 55.04% to $1.8 million in 2024, then tumbled by 37.22% to $1.1 million in 2025.
  • Its last three reported values are $1.1 million in Q3 2025, $1.3 million for Q2 2025, and $1.1 million during Q1 2025.